Molecular Blood Test Diagnoses Herpes Simplex Virus Infection
By LabMedica International staff writers Posted on 07 Nov 2012 |
Polymerase chain reaction (PCR) is now the test of choice for identifying central nervous system infection caused by herpes simplex virus (HSV).
A longitudinal review of HSV PCR testing at two pediatric academic medical centers in the USA determined the clinical features of children positive for serum HSV through PCR testing.
Scientists at the University of Texas Southwestern Medical Center (Dallas, TX, USA) in collaboration with others carried out a retrospective review of all patients who had a serum HSV PCR test at the participating institutions from 2005 to 2010. The study focused on children with one positive blood HSV PCR test and reviewed their charts for demographic, clinical, and other data. They defined a neonatal HSV infection as occurring before 42 days of age.
More than 700 patients received blood HSV PCR testing during the study period. Of those children, 294 were infants younger than 42 days old. A positive HSV PCR test was found in 45 patients (6.1%), 21 of whom were infants. Of these infants, approximately 25% were diagnosed with skin, eye, and mouth HSV disease; another 25% were diagnosed with central nervous system HSV disease; and approximately 50% had disseminated HSV disease. One third of the neonatal HSV patients in this study died. For two of those infants, the blood HSV PCR was the only positive HSV test. In another four children, the blood HSV PCR was the first test that was positive.
Among the 24 older children with positive blood HSV PCR tests, 50% were immunocompromised. Another 29% suffered from atopic dermatitis. Mucocutaneous lesions were much more common, occurring in 92% of these older children and 13% of the older children died. In four of the older children, the blood HSV PCR was the only positive test, and it was the first positive test in another seven of these children, all of whom had vesicular lesions that would have clinically suggested an HSV diagnosis. The authors concluded that HSV PCR testing on serum samples can be a useful adjunct in the diagnosis of HSV, especially among young infants who are much less likely than older children to have mucocutaneous lesions. The study was published in the August 2012 edition of the Journal of Pediatrics.
Related Links:
University of Texas Southwestern Medical Center
A longitudinal review of HSV PCR testing at two pediatric academic medical centers in the USA determined the clinical features of children positive for serum HSV through PCR testing.
Scientists at the University of Texas Southwestern Medical Center (Dallas, TX, USA) in collaboration with others carried out a retrospective review of all patients who had a serum HSV PCR test at the participating institutions from 2005 to 2010. The study focused on children with one positive blood HSV PCR test and reviewed their charts for demographic, clinical, and other data. They defined a neonatal HSV infection as occurring before 42 days of age.
More than 700 patients received blood HSV PCR testing during the study period. Of those children, 294 were infants younger than 42 days old. A positive HSV PCR test was found in 45 patients (6.1%), 21 of whom were infants. Of these infants, approximately 25% were diagnosed with skin, eye, and mouth HSV disease; another 25% were diagnosed with central nervous system HSV disease; and approximately 50% had disseminated HSV disease. One third of the neonatal HSV patients in this study died. For two of those infants, the blood HSV PCR was the only positive HSV test. In another four children, the blood HSV PCR was the first test that was positive.
Among the 24 older children with positive blood HSV PCR tests, 50% were immunocompromised. Another 29% suffered from atopic dermatitis. Mucocutaneous lesions were much more common, occurring in 92% of these older children and 13% of the older children died. In four of the older children, the blood HSV PCR was the only positive test, and it was the first positive test in another seven of these children, all of whom had vesicular lesions that would have clinically suggested an HSV diagnosis. The authors concluded that HSV PCR testing on serum samples can be a useful adjunct in the diagnosis of HSV, especially among young infants who are much less likely than older children to have mucocutaneous lesions. The study was published in the August 2012 edition of the Journal of Pediatrics.
Related Links:
University of Texas Southwestern Medical Center
Latest Microbiology News
- Viral Load Tests Can Help Predict Mpox Severity
- Gut Microbiota Analysis Enables Early and Non-Invasive Detection of Gestational Diabetes
- Credit Card-Sized Test Boosts TB Detection in HIV Hotspots
- Fecal Metabolite Profiling Predicts Mortality in Critically Ill Patients
- Portable Molecular POC System Rules Out UTIs in Just 35 Minutes
- POC Lateral Flow Test Detects Deadly Fungal Infection Faster Than Existing Techniques
- Rapid Diagnostic Test Slashes Sepsis Mortality by 39%
- Blood Culture Assay Enhances Diagnostic Stewardship Through Targeted Panel Selection
- Real-Time Genome Sequencing Detects Dangerous Superbug Causing Hospital Infections
- Diagnostic Test Accurately Detects Colorectal Cancer by Identifying Microbial Signature in Gut Bacteria
- Rapid Bedside Test Predicts Sepsis with Over 90% Accuracy
- New Blood Test Detects Up to Five Infectious Diseases at POC
- Molecular Stool Test Shows Potential for Diagnosing TB in Adults with HIV
- New Test Diagnoses Bacterial Meningitis Quickly and Accurately
- Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
- New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Channels
Clinical Chemistry
view channel
New Clinical Chemistry Analyzer Designed to Meet Growing Demands of Modern Labs
A new clinical chemistry analyzer is designed to provide outstanding performance and maximum efficiency, without compromising affordability, to meet the growing demands of modern laboratories.... Read more
New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
Nucleic acid amplification tests (NAATs) play a key role in diagnosing a wide range of infectious diseases. These tests are generally known for their high sensitivity and specificity, and they can be developed... Read moreMolecular Diagnostics
view channel
DNA Methylation Signatures of Aging Could Help Assess Mortality Risk
Aging is associated with the progressive degeneration and loss of function across multiple physiological systems. Chronological age is the most common indicator of aging; however, there is significant... Read more
Molecular Diagnostics System Provides Lab-Quality Results at POC
Currently, there is a need for a comprehensive molecular diagnostics ecosystem that enables effective diagnostic stewardship, providing the diagnostic tools to offer the right tests, for the right patient,... Read moreHematology
view channel
Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results
Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read moreImmunology
view channel
Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer
Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more
Groundbreaking Lateral Flow Test Quantifies Nucleosomes in Whole Venous Blood in Minutes
Diagnosing immune disruptions quickly and accurately is crucial in conditions such as sepsis, where timely intervention is critical for patient survival. Traditional testing methods can be slow, expensive,... Read morePathology
view channel
AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care
Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more
AI Tool Enhances Interpretation of Tissue Samples by Pathologists
Malignant melanoma, a form of skin cancer, is diagnosed by pathologists based on tissue samples. A crucial aspect of this process is estimating the presence of tumor-infiltrating lymphocytes (TILs), immune... Read more
AI-Assisted Technique Tracks Cells Damaged from Injury, Aging and Disease
Senescent cells, which stop growing and reproducing due to injury, aging, or disease, play a critical role in wound repair and aging-related diseases like cancer and heart disease. These cells, however,... Read more
Novel Fluorescent Probe Shows Potential in Precision Cancer Diagnostics and Fluorescence-Guided Surgery
Hepatocellular carcinoma (HCC), a common type of liver cancer, is difficult to diagnose early and accurately due to the limitations of current diagnostic methods. Glycans, carbohydrate structures present... Read moreTechnology
view channel
Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation
Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Ultra-Sensitive Biosensor Based on Light and AI Enables Early Cancer Diagnosis
Cancer diagnosis is often delayed due to the difficulty in detecting early-stage cancer markers. In particular, the concentration of methylated DNA in the bloodstream during the early stages of cancer... Read moreIndustry
view channel
Quanterix Completes Acquisition of Akoya Biosciences
Quanterix Corporation (Billerica, MA, USA) has completed its previously announced acquisition of Akoya Biosciences (Marlborough, MA, USA), paving the way for the creation of the first integrated solution... Read more
Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis
Lunit (Seoul, South Korea) and Microsoft (Redmond, WA, USA) have entered into a collaboration to accelerate the delivery of artificial intelligence (AI)-powered healthcare solutions. In conjunction with... Read more